Back

Cardiovascular drug development: role of Mendelian randomization

European Heart Journal

28 March 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY Research Methodology PREVENTIVE CARDIOLOGY Risk Factors and Prevention BASIC SCIENCE

Contributors

Jonathan L Ciofani
Jonathan L Ciofani

Author

University of Sydney Sydney , Australia

Anne Tybjærg-Hansen
Anne Tybjærg-Hansen

Author

Ravinay Bhindi
Ravinay Bhindi

Author

You may be interested in
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023
thumbnail
Congress Session
HFA clinical trial course in a nutshell
17 May 2025
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources